{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,21]],"date-time":"2026-10-21T18:11:39Z","timestamp":1792606299132,"version":"4.5.0"},"reference-count":100,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2024,9,1]],"date-time":"2024-09-01T00:00:00Z","timestamp":1725148800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,9,1]],"date-time":"2024-09-01T00:00:00Z","timestamp":1725148800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2024,7,24]],"date-time":"2024-07-24T00:00:00Z","timestamp":1721779200000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/100004334","name":"Merck & Co Inc","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100004334","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","ejog.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["European Journal of Obstetrics & Gynecology and Reproductive Biology"],"published-print":{"date-parts":[[2024,9]]},"DOI":"10.1016\/j.ejogrb.2024.06.030","type":"journal-article","created":{"date-parts":[[2024,7,1]],"date-time":"2024-07-01T13:15:22Z","timestamp":1719839722000},"page":"129-140","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":12,"special_numbering":"C","title":["Treatment characteristics, HPV genotype distribution and risk of subsequent disease among women with high-grade cervical intraepithelial neoplasia in Europe: A systematic literature review"],"prefix":"10.1016","volume":"300","author":[{"given":"Miriam","family":"Reuschenbach","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stefano","family":"Valente","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jitender","family":"Takyar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Arju","family":"Dhawan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Adam","family":"Hall","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Neha","family":"Agrawal","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alessandro","family":"Ghelardi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marta","family":"del Pino","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andrzej","family":"Nowakowski","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ugne","family":"Sabale","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"2","key":"10.1016\/j.ejogrb.2024.06.030_b0005","first-page":"80","article-title":"Review of HPV-related diseases and cancers","volume":"40","author":"Brianti","year":"2017","journal-title":"New Microbiol"},{"key":"10.1016\/j.ejogrb.2024.06.030_b0010","series-title":"Human papillomavirus infections: epidemiology and disease associations","author":"Palefsky","year":"2018"},{"key":"10.1016\/j.ejogrb.2024.06.030_b0015","series-title":"Cervical intraepithelial neoplasia: management","author":"Wright","year":"2022"},{"key":"10.1016\/j.ejogrb.2024.06.030_b0020","series-title":"Cervical intraepithelial neoplasia","author":"Courtney","year":"2022"},{"key":"10.1016\/j.ejogrb.2024.06.030_b0025","unstructured":"Prendiville W, Sankaranarayanan R. Chapter 3. Squamous intraepithelial lesions: cytology\u2013histology correlation. Colposcopy and Treatment of Cervical Precancer Lyon (FR): International Agency for Research on Cancer; 2017 (IARC Technical Report, No 45) Available from: https:\/\/wwwncbinlmnihgov\/books\/NBK568361\/#."},{"key":"10.1016\/j.ejogrb.2024.06.030_b0030","series-title":"WHO guidelines for treatment of cervical intraepithelial neoplasia 2\u20133 and adenocarcinoma in situ: cryotherapy, large loop excision of the transformation zone, and cold knife conization","author":"WHO","year":"2014"},{"key":"10.1016\/j.ejogrb.2024.06.030_b0035","unstructured":"WHO. Chapter 2: An Introduction to Cervical Intraepithelial Neoplasia (CIN). Colposcopy and treatment of cervical intraepithelial neoplasia: a beginners\u2019 manual, Edited by JW Sellors and R Sankaranarayanan. 2003; https:\/\/screening.iarc.fr\/colpochap.php?chap=2."},{"key":"10.1016\/j.ejogrb.2024.06.030_b0040","first-page":"748","article-title":"Natural history of cervical intra epithelial neoplasia","volume":"5","author":"Richart","year":"1968","journal-title":"Clin Obstet Gynecol"},{"issue":"1","key":"10.1016\/j.ejogrb.2024.06.030_b0045","first-page":"131","article-title":"A modified terminology for cervical intraepithelial neoplasia","volume":"75","author":"Richart","year":"1990","journal-title":"Obstet Gynecol"},{"key":"10.1016\/j.ejogrb.2024.06.030_b0050","unstructured":"European Commission. Cervical cancer burden in EU-27. https:\/\/ecisjrceceuropaeu\/pdf\/factsheets\/cervical_cancer_en-Nov_2021pdf. 2021."},{"key":"10.1016\/j.ejogrb.2024.06.030_b0055","unstructured":"WHO. Cervical cancer fact sheet. Last Updated: 22 February 2022. https:\/\/wwwwhoint\/news-room\/fact-sheets\/detail\/cervical-cancer 2022."},{"key":"10.1016\/j.ejogrb.2024.06.030_b0060","unstructured":"Shafi DM. European Quality Standards for the Treatment of Cervical Intraepithelial Neoplasia (CIN) 2007; European Federation for Colposcopy 2007 [Available from: https:\/\/efcolposcopy.eu\/european-quality-standards-for-the-treatment-of-cervical-intraepithelial-neoplasia-cin-2007\/."},{"issue":"2","key":"10.1016\/j.ejogrb.2024.06.030_b0065","doi-asserted-by":"crossref","first-page":"102","DOI":"10.1097\/LGT.0000000000000525","article-title":"2019 ASCCP risk-based management consensus guidelines for abnormal cervical cancer screening tests and cancer precursors","volume":"24","author":"Perkins","year":"2020","journal-title":"J Low Genit Tract Dis"},{"key":"10.1016\/j.ejogrb.2024.06.030_b0070","series-title":"Cervical intraepithelial neoplasia","author":"Mello","year":"2021"},{"issue":"4","key":"10.1016\/j.ejogrb.2024.06.030_b0075","doi-asserted-by":"crossref","first-page":"829","DOI":"10.1097\/AOG.0b013e3182883a34","article-title":"2012 updated consensus guidelines for the management of abnormal cervical cancer screening tests and cancer precursors","volume":"121","author":"Massad","year":"2013","journal-title":"Obstet Gynecol"},{"issue":"3","key":"10.1016\/j.ejogrb.2024.06.030_b0080","doi-asserted-by":"crossref","first-page":"641","DOI":"10.1002\/ijc.32752","article-title":"Risk of cervical intraepithelial neoplasia grade 2 or worse after conization in relation to HPV vaccination status","volume":"147","author":"Sand","year":"2020","journal-title":"Int J Cancer"},{"issue":"3","key":"10.1016\/j.ejogrb.2024.06.030_b0085","doi-asserted-by":"crossref","first-page":"636","DOI":"10.1016\/j.ygyno.2020.08.025","article-title":"Recurrence rate after loop electrosurgical excision procedure (LEEP) and laser Conization: A 5-year follow-up study","volume":"159","author":"Bogani","year":"2020","journal-title":"Gynecol Oncol"},{"issue":"22","key":"10.1016\/j.ejogrb.2024.06.030_b0090","doi-asserted-by":"crossref","first-page":"2542","DOI":"10.1200\/JCO.2016.71.4543","article-title":"Long-lasting increased risk of human papillomavirus-related carcinomas and premalignancies after cervical intraepithelial neoplasia grade 3: a population-based cohort study","volume":"35","author":"Ebisch","year":"2017","journal-title":"J Clin Oncol"},{"issue":"1","key":"10.1016\/j.ejogrb.2024.06.030_b0095","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1002\/ijc.30623","article-title":"Patterns of persistent HPV infection after treatment for cervical intraepithelial neoplasia (CIN): a systematic review","volume":"141","author":"Hoffman","year":"2017","journal-title":"Int J Cancer"},{"issue":"42","key":"10.1016\/j.ejogrb.2024.06.030_b0100","doi-asserted-by":"crossref","first-page":"6194","DOI":"10.1016\/j.vaccine.2023.08.047","article-title":"Prophylactic HPV vaccines in patients with HPV-associated diseases and cancer","volume":"41","author":"Reuschenbach","year":"2023","journal-title":"Vaccine"},{"issue":"6","key":"10.1016\/j.ejogrb.2024.06.030_b0105","doi-asserted-by":"crossref","first-page":"377","DOI":"10.1136\/jech.52.6.377","article-title":"The feasibility of creating a checklist for the assessment of the methodological quality both of randomised and non-randomised studies of health care interventions","volume":"52","author":"Downs","year":"1998","journal-title":"J Epidemiol Community Health"},{"key":"10.1016\/j.ejogrb.2024.06.030_b0110","unstructured":"WHO. WHO guideline for screening and treatment of cervical pre-cancer lesions for cervical cancer prevention. 2nd Edition. Available from: https:\/\/iris.who.int\/bitstream\/handle\/10665\/342365\/9789240030824-eng.pdf. 2021."},{"issue":"6","key":"10.1016\/j.ejogrb.2024.06.030_b0115","doi-asserted-by":"crossref","first-page":"1465","DOI":"10.1097\/AOG.0b013e31827001d5","article-title":"Revised terminology for cervical histopathology and its implications for management of high-grade squamous intraepithelial lesions of the cervix","volume":"120","author":"Waxman","year":"2012","journal-title":"Obstet Gynecol"},{"issue":"6","key":"10.1016\/j.ejogrb.2024.06.030_b0120","doi-asserted-by":"crossref","first-page":"737","DOI":"10.1111\/aogs.13547","article-title":"Management and treatment of cervical intraepithelial neoplasia in the Netherlands after referral for colposcopy","volume":"98","author":"Aitken","year":"2019","journal-title":"Acta Obstet Gynecol Scand"},{"issue":"2","key":"10.1016\/j.ejogrb.2024.06.030_b0125","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1097\/CEJ.0000000000000432","article-title":"Artificial intelligence estimates the impact of human papillomavirus types in influencing the risk of cervical dysplasia recurrence: progress toward a more personalized approach","volume":"28","author":"Bogani","year":"2019","journal-title":"Eur J Cancer Prev"},{"issue":"11","key":"10.1016\/j.ejogrb.2024.06.030_b0130","doi-asserted-by":"crossref","first-page":"1475","DOI":"10.1097\/QAD.0000000000001853","article-title":"Suppressive antiretroviral therapy associates with effective treatment of high-grade cervical intraepithelial neoplasia","volume":"32","author":"Carlander","year":"2018","journal-title":"AIDS"},{"issue":"3","key":"10.1016\/j.ejogrb.2024.06.030_b0135","article-title":"Outcome of cin 2 treatment over a 10-year period","volume":"19","author":"Dwivedi","year":"2021","journal-title":"Indian J Gynecol Oncol"},{"issue":"12","key":"10.1016\/j.ejogrb.2024.06.030_b0140","first-page":"732","article-title":"Conservative management of biopsy confirmed high-grade squamous intraepithelial lesions","volume":"118","author":"Hederlingova","year":"2017","journal-title":"Bratisl Lek Listy"},{"issue":"1","key":"10.1016\/j.ejogrb.2024.06.030_b0145","doi-asserted-by":"crossref","first-page":"142","DOI":"10.1016\/j.ygyno.2013.11.001","article-title":"How distressing is referral to colposcopy in cervical cancer screening?: a prospective quality of life study","volume":"132","author":"Korfage","year":"2014","journal-title":"Gynecol Oncol"},{"issue":"12","key":"10.1016\/j.ejogrb.2024.06.030_b0150","doi-asserted-by":"crossref","first-page":"1663","DOI":"10.1080\/0284186X.2018.1497296","article-title":"Low proportion of unreported cervical treatments in the cancer registry of Norway between 1998 and 2013","volume":"57","author":"Leinonen","year":"2018","journal-title":"Acta Oncol"},{"issue":"2","key":"10.1016\/j.ejogrb.2024.06.030_b0155","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1111\/cyt.12516","article-title":"Prevalence of high-grade cervical intraepithelial neoplasia in women with persistent high-risk HPV genotypes and negative cytology","volume":"29","author":"Macdonald","year":"2018","journal-title":"Cytopathology"},{"key":"10.1016\/j.ejogrb.2024.06.030_b0160","doi-asserted-by":"crossref","unstructured":"Ofinran OT, Onnig. Outcome of women with postcoital bleeding referred for colposcopy. Gazzetta Medica Italiana Archivio per le Scienze Mediche 2019;178(3).","DOI":"10.23736\/S0393-3660.18.03637-9"},{"issue":"4","key":"10.1016\/j.ejogrb.2024.06.030_b0165","doi-asserted-by":"crossref","first-page":"979","DOI":"10.1007\/s00404-017-4306-z","article-title":"Comparison of cure rates in women treated with cold-coagulation versus LLETZ cervical treatment for CIN2-3 on pretreatment cervical punch biopsies: a retrospective cohort study","volume":"295","author":"Papoutsis","year":"2017","journal-title":"Arch Gynecol Obstet"},{"key":"10.1016\/j.ejogrb.2024.06.030_b0170","doi-asserted-by":"crossref","unstructured":"Przybylski MM-K, S. Zmaczynski, A. Baran, R. Zaborowska, L. Jach, R. Pruski, D. Human papillomavirus genotyping in high-grade squamous intraepithelial lesion. Ginekol Pol 2022a.","DOI":"10.5603\/GP.a2021.0167"},{"issue":"10","key":"10.1016\/j.ejogrb.2024.06.030_b0175","doi-asserted-by":"crossref","first-page":"1260","DOI":"10.1111\/1471-0528.16250","article-title":"The impact of age and high-risk human papillomavirus (hrHPV) status on the prevalence of high-grade cervical intraepithelial neoplasia (CIN2+) in women with persistent hrHPV-positive, cytology-negative screening samples: a prospective cohort study","volume":"127","author":"Tidy","year":"2020","journal-title":"BJOG"},{"key":"10.1016\/j.ejogrb.2024.06.030_b0180","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1155\/2022\/7955290","article-title":"Comparison of expectant and excisional\/ablative management of Cervical Intraepithelial Neoplasia grade 2 (CIN2) in the era of HPV testing","volume":"2022","author":"Tjandraprawira","year":"2022","journal-title":"Obstet Gynecol Int"},{"issue":"2","key":"10.1016\/j.ejogrb.2024.06.030_b0185","doi-asserted-by":"crossref","first-page":"172.e1","DOI":"10.1016\/j.ajog.2019.08.042","article-title":"Incomplete excision of cervical intraepithelial neoplasia as a predictor of the risk of recurrent disease\u2014a 16-year follow-up study","volume":"222","author":"Alder","year":"2020","journal-title":"Am J Obstetr Gynecol"},{"issue":"2","key":"10.1016\/j.ejogrb.2024.06.030_b0190","doi-asserted-by":"crossref","first-page":"126","DOI":"10.1097\/LGT.0000000000000600","article-title":"Follow-up after loop electrosurgical excision of cervical intraepithelial neoplasia: the use of combined cytology and human papillomavirus testing","volume":"25","author":"Anderson","year":"2021","journal-title":"J Low Genit Tract Dis"},{"issue":"4","key":"10.1016\/j.ejogrb.2024.06.030_b0195","article-title":"Development of a Nomogram Predicting the Risk of Persistence\/Recurrence of Cervical Dysplasia","volume":"10","author":"Bogani","year":"2022","journal-title":"Vaccines (Basel)"},{"issue":"1","key":"10.1016\/j.ejogrb.2024.06.030_b0200","doi-asserted-by":"crossref","first-page":"148","DOI":"10.1186\/s12985-019-1252-3","article-title":"HPV16 persistent infection and recurrent disease after LEEP","volume":"16","author":"Bruno","year":"2019","journal-title":"Virol J"},{"issue":"6","key":"10.1016\/j.ejogrb.2024.06.030_b0205","first-page":"413","article-title":"High grade cervical intraepithelial neoplasia positive biopsy: the importance of accurate pre-operative workup","volume":"72","author":"Bussani","year":"2020","journal-title":"Minerva Ginecol"},{"key":"10.1016\/j.ejogrb.2024.06.030_b0210","doi-asserted-by":"crossref","unstructured":"A. Del Mistro M. Matteucci E.A. Insacco G. Onnis F. Da Re L. Baboci et al. Long-term clinical outcome after treatment for high-grade cervical lesions: a Retrospective monoinstitutional cohort study. Biomed Res Int 2015;2015:984528.","DOI":"10.1155\/2015\/984528"},{"key":"10.1016\/j.ejogrb.2024.06.030_b0215","article-title":"Benefits of hpv vaccination as adjuvant to cervical treatment in women with intraepithelial neoplasia","author":"Del Pino","year":"2020","journal-title":"IPVC."},{"issue":"1","key":"10.1016\/j.ejogrb.2024.06.030_b0220","doi-asserted-by":"crossref","first-page":"18","DOI":"10.1097\/LGT.0000000000000423","article-title":"Risk factors of post-large loop excision of the transformation zone recurrent high-grade cervical intraepithelial lesion: a prospective cohort study","volume":"23","author":"Demarquet","year":"2019","journal-title":"J Low Genit Tract Dis"},{"issue":"3","key":"10.1016\/j.ejogrb.2024.06.030_b0225","doi-asserted-by":"crossref","first-page":"377","DOI":"10.1111\/1471-0528.15996","article-title":"Long-term predictors of residual or recurrent cervical intraepithelial neoplasia 2\u20133 after treatment with a large loop excision of the transformation zone: a retrospective study","volume":"127","author":"Fernandez-Montoli","year":"2020","journal-title":"BJOG"},{"issue":"1","key":"10.1016\/j.ejogrb.2024.06.030_b0230","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1016\/j.jcv.2014.01.017","article-title":"Assessment of HPV-mRNA test to predict recurrent disease in patients previously treated for CIN 2\/3","volume":"60","author":"Frega","year":"2014","journal-title":"J Clin Virol"},{"issue":"02","key":"10.1016\/j.ejogrb.2024.06.030_b0235","article-title":"Loop Electrosurgical excision procedure and cold knife conization: which is the best? A large retrospective study","volume":"34","author":"Galli","year":"2022","journal-title":"Ital J Gynaecol Obstetr"},{"issue":"4","key":"10.1016\/j.ejogrb.2024.06.030_b0240","doi-asserted-by":"crossref","first-page":"287","DOI":"10.1097\/LGT.0000000000000625","article-title":"Efficacy of human papillomavirus vaccination 4 years after conization for high-grade cervical neoplasia","volume":"25","author":"Gomez","year":"2021","journal-title":"J Low Genit Tract Dis"},{"issue":"4","key":"10.1016\/j.ejogrb.2024.06.030_b0245","doi-asserted-by":"crossref","first-page":"405","DOI":"10.1111\/aogs.12601","article-title":"Role of human papillomavirus testing and cytology in follow-up after conization","volume":"94","author":"Gosvig","year":"2015","journal-title":"Acta Obstet Gynecol Scand"},{"issue":"6","key":"10.1016\/j.ejogrb.2024.06.030_b0250","article-title":"HPV vaccination in women with cervical intraepithelial neoplasia undergoing excisional treatment: insights into unsolved questions","volume":"10","author":"Henere","year":"2022","journal-title":"Vaccines (Basel)"},{"issue":"1","key":"10.1016\/j.ejogrb.2024.06.030_b0255","doi-asserted-by":"crossref","first-page":"394","DOI":"10.1186\/s12905-021-01537-5","article-title":"Can biopsies be omitted after normal colposcopy in women referred with low-grade cervical cytology? A prospective cohort study","volume":"21","author":"Jespersen","year":"2021","journal-title":"BMC Womens Health"},{"key":"10.1016\/j.ejogrb.2024.06.030_b0260","doi-asserted-by":"crossref","DOI":"10.1016\/j.ygyno.2022.09.016","article-title":"Overtreatment rate after immediate local excision of suspected cervical intraepithelial neoplasia: a prospective cohort study","author":"Kiviharju","year":"2022","journal-title":"Gynecol Oncol"},{"issue":"4","key":"10.1016\/j.ejogrb.2024.06.030_b0265","doi-asserted-by":"crossref","DOI":"10.1097\/MD.0000000000009719","article-title":"Low recurrence rate of high-grade cervical intraepithelial neoplasia after successful excision and routine colposcopy during follow-up","volume":"97","author":"Lili","year":"2018","journal-title":"Medicine (Baltimore)"},{"key":"10.1016\/j.ejogrb.2024.06.030_b0270","doi-asserted-by":"crossref","unstructured":"Loopik DLS, Melchers AG, Massuger WJG, Lfag Bekkers RLM. Clinical practice variation and overtreatment risk in women with abnormal cervical cytology in the Netherlands: two-step versus see-and-treat approach. Am J Obstet Gynecol 2020b;222(4):354 e1-e10.","DOI":"10.1016\/j.ajog.2019.10.004"},{"issue":"1","key":"10.1016\/j.ejogrb.2024.06.030_b0275","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1016\/j.ejogrb.2011.11.023","article-title":"Follow-up after LLETZ: a study of 682 cases of CIN 2-CIN 3 in a single institution","volume":"161","author":"Lubrano","year":"2012","journal-title":"Eur J Obstet Gynecol Reprod Biol"},{"key":"10.1016\/j.ejogrb.2024.06.030_b0280","article-title":"Are women with incomplete excision margins more likely to have residual high-grade disease at their post-treatment smear?","volume":"123","author":"Marcus","year":"2016","journal-title":"BJOG"},{"key":"10.1016\/j.ejogrb.2024.06.030_b0285","doi-asserted-by":"crossref","first-page":"225","DOI":"10.1016\/j.ejogrb.2016.05.029","article-title":"The use and success of cold coagulation for the treatment of high grade squamous cervical intra-epithelial neoplasia: a retrospective review","volume":"203","author":"McCarthy","year":"2016","journal-title":"Eur J Obstet Gynecol Reprod Biol"},{"issue":"4","key":"10.1016\/j.ejogrb.2024.06.030_b0290","doi-asserted-by":"crossref","DOI":"10.1016\/j.jogoh.2022.102341","article-title":"Laser conization for cervical intraepithelial neoplasia: effectiveness and obstetric outcomes","volume":"51","author":"Mosseri","year":"2022","journal-title":"J Gynecol Obstet Hum Reprod"},{"issue":"3","key":"10.1016\/j.ejogrb.2024.06.030_b0295","first-page":"402","article-title":"Impact of the human papillomavirus vaccination on patients who underwent conization for high-grade cervical intraepithelial neoplasia","volume":"40","author":"Ortega-Qui\u00f1onero","year":"2019","journal-title":"Eur J Gynaecol Oncol"},{"key":"10.1016\/j.ejogrb.2024.06.030_b0300","doi-asserted-by":"crossref","unstructured":"Przybylski MP, D. Millert-Kalinska, S. Zmaczynski, A. Baran, R. Horbaczewska, A. Jach, R. Zaborowska, L. Remission of HPV infection after LEEP-conization \u2212 a retrospective study. Ginekol Pol 2022b.","DOI":"10.5603\/GP.a2021.0164"},{"issue":"1","key":"10.1016\/j.ejogrb.2024.06.030_b0305","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1111\/1471-0528.15932","article-title":"Evaluation of the intraoperative human papillomavirus test as a marker of early cure at 12 months after electrosurgical excision procedure in women with cervical high-grade squamous intraepithelial lesion: a prospective cohort study","volume":"127","author":"Rabasa","year":"2020","journal-title":"BJOG"},{"issue":"2","key":"10.1016\/j.ejogrb.2024.06.030_b0310","doi-asserted-by":"crossref","first-page":"240","DOI":"10.1002\/ijgo.12431","article-title":"Risk factors for HPV persistence and cytology anomalies at follow-up after treatment for cervical dysplasia","volume":"141","author":"Rizzuto","year":"2018","journal-title":"Int J Gynaecol Obstet"},{"issue":"3","key":"10.1016\/j.ejogrb.2024.06.030_b0315","first-page":"245","article-title":"Human papillomavirus combined with cytology and margin status identifies patients at risk for recurrence after conization for high-grade cervical intraepithelial neoplasia","volume":"36","author":"Ruano","year":"2015","journal-title":"Eur J Gynaecol Oncol"},{"key":"10.1016\/j.ejogrb.2024.06.030_b0320","doi-asserted-by":"crossref","DOI":"10.36469\/jheor.2022.35329","article-title":"Healthcare costs and resource use associated with cervical intraepithelial neoplasia and cervical conization: a retrospective study of German statutory health insurance claims data","author":"Stephan","year":"2022","journal-title":"J Health Econ Outcomes Res"},{"issue":"8","key":"10.1016\/j.ejogrb.2024.06.030_b0325","first-page":"1458","article-title":"The mRNA-HPV test utilization in the follow up of HPV related cervical lesions","volume":"19","author":"Tinelli","year":"2013","journal-title":"Curr Pharm Des"},{"issue":"4","key":"10.1016\/j.ejogrb.2024.06.030_b0330","doi-asserted-by":"crossref","first-page":"392","DOI":"10.1111\/1471-0528.12072","article-title":"Intraoperative post-conisation human papillomavirus testing for early detection of treatment failure in patients with cervical intraepithelial neoplasia: a pilot study","volume":"120","author":"Torne","year":"2012","journal-title":"BJOG"},{"issue":"1","key":"10.1016\/j.ejogrb.2024.06.030_b0335","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1016\/j.ygyno.2016.07.089","article-title":"Performance of CADM1\/MAL-methylation analysis for monitoring of women treated for high-grade CIN","volume":"143","author":"Uijterwaal","year":"2016","journal-title":"Gynecol Oncol"},{"issue":"8","key":"10.1016\/j.ejogrb.2024.06.030_b0340","first-page":"1450","article-title":"Detection of residual\/recurrent cervical disease after successful LEEP conization: the possible role of mRNA-HPV test","volume":"19","author":"Zappacosta","year":"2013","journal-title":"Curr Pharm Des"},{"issue":"4","key":"10.1016\/j.ejogrb.2024.06.030_b0345","doi-asserted-by":"crossref","first-page":"459","DOI":"10.1097\/LGT.0b013e3182838b7c","article-title":"High-Grade squamou intraepithelial lesion could be managed conservatively in women up to 25 years: results from a retrospective cohort study","volume":"17","author":"Agramunt","year":"2013","journal-title":"J Low Genit Tract Dis"},{"issue":"5","key":"10.1016\/j.ejogrb.2024.06.030_b0350","doi-asserted-by":"crossref","DOI":"10.3802\/jgo.2020.31.e60","article-title":"Age-specific predictors of cervical dysplasia recurrence after primary conization: analysis of 3,212 women","volume":"31","author":"Bogani","year":"2020","journal-title":"J Gynecol Oncol"},{"issue":"6","key":"10.1016\/j.ejogrb.2024.06.030_b0355","doi-asserted-by":"crossref","first-page":"758","DOI":"10.1111\/aogs.13325","article-title":"HPV-testing versus HPV-cytology co-testing to predict the outcome after conization","volume":"97","author":"Bruhn","year":"2018","journal-title":"Acta Obstet Gynecol Scand"},{"key":"10.1016\/j.ejogrb.2024.06.030_b0360","article-title":"Risk of recurrent disease after conization according to timing of hpv vaccination in relation to treatment","author":"Sand","year":"2022","journal-title":"EUROGIN"},{"issue":"7","key":"10.1016\/j.ejogrb.2024.06.030_b0365","doi-asserted-by":"crossref","first-page":"852","DOI":"10.1111\/aogs.12116","article-title":"Long-term adherence to follow-up after treatment of cervical intraepithelial neoplasia: nationwide population-based study","volume":"92","author":"Barken","year":"2013","journal-title":"Acta Obstet Gynecol Scand"},{"issue":"6","key":"10.1016\/j.ejogrb.2024.06.030_b0370","doi-asserted-by":"crossref","first-page":"758","DOI":"10.1111\/cyt.13044","article-title":"Are we managing our patients correctly following treatment for cervical glandular intraepithelial neoplasia? A review of practice at the Jessop Wing Colposcopy Unit","volume":"32","author":"Magro","year":"2021","journal-title":"Cytopathology"},{"issue":"9","key":"10.1016\/j.ejogrb.2024.06.030_b0375","doi-asserted-by":"crossref","first-page":"1759","DOI":"10.1002\/ijc.31202","article-title":"Long-term risk of cervical cancer following conization of cervical intraepithelial neoplasia grade 3-A Danish nationwide cohort study","volume":"142","author":"Sand","year":"2018","journal-title":"Int J Cancer"},{"issue":"2","key":"10.1016\/j.ejogrb.2024.06.030_b0380","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1016\/j.ygyno.2014.03.004","article-title":"Recurrent high-grade cervical lesion after primary conization is associated with persistent human papillomavirus infection in Norway","volume":"133","author":"Vintermyr","year":"2014","journal-title":"Gynecol Oncol"},{"issue":"1","key":"10.1016\/j.ejogrb.2024.06.030_b0385","doi-asserted-by":"crossref","first-page":"195","DOI":"10.1016\/j.ygyno.2020.01.023","article-title":"The risk of cervical cancer after cervical intraepithelial neoplasia grade 3: A population-based cohort study with 80,442 women","volume":"157","author":"Loopik","year":"2020","journal-title":"Gynecol Oncol"},{"key":"10.1016\/j.ejogrb.2024.06.030_b0390","unstructured":"World Health Organization. WHO guidelines for treatment of cervical intraepithelial neoplasia 2\u20133 and adenocarcinoma in situ: cryotherapy, large loop excision of the transformation zone, and cold knife conization 2014."},{"issue":"1","key":"10.1016\/j.ejogrb.2024.06.030_b0395","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1111\/j.1365-2303.2008.00636.x","article-title":"European guidelines for clinical management of abnormal cervical cytology, Part 2","volume":"20","author":"Jordan","year":"2009","journal-title":"Cytopathology"},{"issue":"3","key":"10.1016\/j.ejogrb.2024.06.030_b0400","doi-asserted-by":"crossref","first-page":"252","DOI":"10.1016\/j.ijgo.2015.07.038","article-title":"World Health Organization Guidelines for treatment of cervical intraepithelial neoplasia 2\u20133 and screen-and-treat strategies to prevent cervical cancer","volume":"132","author":"Santesso","year":"2016","journal-title":"Int J Gynecol Obstet"},{"issue":"11","key":"10.1016\/j.ejogrb.2024.06.030_b0405","article-title":"Obstetric outcomes after conservative treatment for cervical intraepithelial lesions and early invasive disease","volume":"2017","author":"Kyrgiou","year":"1996","journal-title":"Cochrane Database Syst Rev"},{"key":"10.1016\/j.ejogrb.2024.06.030_b0410","first-page":"354","article-title":"Adverse obstetric outcomes after local treatment for cervical preinvasive and early invasive disease according to cone depth: systematic review and meta-analysis","author":"Kyrgiou","year":"2016","journal-title":"BMJ"},{"issue":"9509","key":"10.1016\/j.ejogrb.2024.06.030_b0415","doi-asserted-by":"crossref","first-page":"489","DOI":"10.1016\/S0140-6736(06)68181-6","article-title":"Obstetric outcomes after conservative treatment for intraepithelial or early invasive cervical lesions: systematic review and meta-analysis","volume":"367","author":"Kyrgiou","year":"2006","journal-title":"Lancet"},{"issue":"4","key":"10.1016\/j.ejogrb.2024.06.030_b0420","doi-asserted-by":"crossref","first-page":"423","DOI":"10.1080\/11038120701208158","article-title":"Pregnancy outcome after cervical cone excision: a case-control study","volume":"86","author":"Donvold Sj\u00f8borg","year":"2007","journal-title":"Acta Obstet Gynecol Scand"},{"key":"10.1016\/j.ejogrb.2024.06.030_b0425","first-page":"337","article-title":"Pregnancy outcome in women before and after cervical conisation: population based cohort study","author":"Albrechtsen","year":"2008","journal-title":"BMJ"},{"issue":"1","key":"10.1016\/j.ejogrb.2024.06.030_b0430","doi-asserted-by":"crossref","first-page":"33.e1","DOI":"10.1016\/j.ajog.2009.02.004","article-title":"Loop electrosurgical excision of the cervix and subsequent risk for spontaneous preterm delivery: a population-based study of singleton deliveries during a 9-year period","volume":"201","author":"Noehr","year":"2009","journal-title":"Am J Obstet Gynecol"},{"issue":"5","key":"10.1016\/j.ejogrb.2024.06.030_b0435","doi-asserted-by":"crossref","first-page":"1063","DOI":"10.1097\/AOG.0b013e31828caa31","article-title":"Loop electrosurgical excision procedure and the risk for preterm delivery","volume":"121","author":"Heinonen","year":"2013","journal-title":"Obstet Gynecol"},{"issue":"9","key":"10.1016\/j.ejogrb.2024.06.030_b0440","doi-asserted-by":"crossref","first-page":"1031","DOI":"10.1111\/j.1471-0528.2011.02944.x","article-title":"The risk of preterm birth following treatment for precancerous changes in the cervix: a systematic review and meta-analysis","volume":"118","author":"Bruinsma","year":"2011","journal-title":"BJOG"},{"issue":"5","key":"10.1016\/j.ejogrb.2024.06.030_b0445","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pmed.1003641","article-title":"Associations of treated and untreated human papillomavirus infection with preterm delivery and neonatal mortality: A Swedish population-based study","volume":"18","author":"Wiik","year":"2021","journal-title":"PLoS Med"},{"issue":"1","key":"10.1016\/j.ejogrb.2024.06.030_b0450","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1186\/s12916-022-02276-6","article-title":"Associations between cervical intraepithelial neoplasia during pregnancy, previous excisional treatment, cone-length and preterm delivery: a register-based study from western Sweden","volume":"20","author":"Wiik","year":"2022","journal-title":"BMC Med"},{"issue":"2","key":"10.1016\/j.ejogrb.2024.06.030_b0455","article-title":"HPV vaccination after primary treatment of HPV-related disease across different organ sites: a multidisciplinary comprehensive review and meta-analysis","volume":"10","author":"Di Donato","year":"2022","journal-title":"Vaccines (Basel)"},{"issue":"5","key":"10.1016\/j.ejogrb.2024.06.030_b0460","article-title":"Adjuvant HPV vaccination to prevent recurrent cervical dysplasia after surgical treatment: a meta-analysis","volume":"9","author":"Di Donato","year":"2021","journal-title":"Vaccines (Basel)"},{"issue":"6","key":"10.1016\/j.ejogrb.2024.06.030_b0465","doi-asserted-by":"crossref","first-page":"597","DOI":"10.1111\/aogs.14359","article-title":"Human papillomavirus vaccination in women undergoing excisional treatment for cervical intraepithelial neoplasia and subsequent risk of recurrence: a systematic review and meta-analysis","volume":"101","author":"Eriksen","year":"2022","journal-title":"Acta Obstet Gynecol Scand"},{"issue":"41","key":"10.1016\/j.ejogrb.2024.06.030_b0470","doi-asserted-by":"crossref","first-page":"6402","DOI":"10.1016\/j.vaccine.2020.07.055","article-title":"Prophylactic HPV vaccination after conization: a systematic review and meta-analysis","volume":"38","author":"Jentschke","year":"2020","journal-title":"Vaccine"},{"issue":"5","key":"10.1016\/j.ejogrb.2024.06.030_b0475","doi-asserted-by":"crossref","first-page":"1070","DOI":"10.1097\/AOG.0000000000003833","article-title":"Adjuvant human papillomavirus vaccine to reduce recurrent cervical dysplasia in unvaccinated women: a systematic review and meta-analysis","volume":"135","author":"Lichter","year":"2020","journal-title":"Obstet Gynecol"},{"issue":"5","key":"10.1016\/j.ejogrb.2024.06.030_b0480","doi-asserted-by":"crossref","first-page":"579","DOI":"10.1016\/j.cmi.2019.09.006","article-title":"Primary HPV-based cervical cancer screening in Europe: implementation status, challenges, and future plans","volume":"26","author":"Maver","year":"2020","journal-title":"Clin Microbiol Infect"},{"issue":"6","key":"10.1016\/j.ejogrb.2024.06.030_b0485","doi-asserted-by":"crossref","first-page":"1028","DOI":"10.1111\/aogs.14827","article-title":"The role of multiple high-risk human papillomavirus infection on the persistence recurrence of high-grade cervical lesions after standard treatment: A systematic review and a meta-analysis","volume":"103","author":"Cassani","year":"2024","journal-title":"Acta Obstet Gynecol Scand"},{"issue":"12","key":"10.1016\/j.ejogrb.2024.06.030_b0490","first-page":"1665","article-title":"Incomplete excision of cervical precancer as a predictor of treatment failure: a systematic review and meta-analysis","volume":"18","author":"Arbyn","year":"2017","journal-title":"LancetOncol"},{"issue":"27","key":"10.1016\/j.ejogrb.2024.06.030_b0495","doi-asserted-by":"crossref","first-page":"e26359","DOI":"10.1097\/MD.0000000000026359","article-title":"Predictors of recurrence in patients with high-grade cervical intraepithelial neoplasia after cervical conization","volume":"100","author":"Ge","year":"2021","journal-title":"Medicine"},{"issue":"2","key":"10.1016\/j.ejogrb.2024.06.030_b0500","doi-asserted-by":"crossref","first-page":"538","DOI":"10.1002\/ijgo.14340","article-title":"Risk factors analysis of recurrent disease after treatment with a loop electrosurgical excision procedure for high-grade cervical intraepithelial neoplasia","volume":"160","author":"Ding","year":"2023","journal-title":"Int J Gynecol Obstet"}],"container-title":["European Journal of Obstetrics & Gynecology and Reproductive Biology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0301211524003191?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0301211524003191?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,11,6]],"date-time":"2025-11-06T19:12:38Z","timestamp":1762456358000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0301211524003191"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,9]]},"references-count":100,"alternative-id":["S0301211524003191"],"URL":"https:\/\/doi.org\/10.1016\/j.ejogrb.2024.06.030","relation":{},"ISSN":["0301-2115"],"issn-type":[{"value":"0301-2115","type":"print"}],"subject":[],"published":{"date-parts":[[2024,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Treatment characteristics, HPV genotype distribution and risk of subsequent disease among women with high-grade cervical intraepithelial neoplasia in Europe: A systematic literature review","name":"articletitle","label":"Article Title"},{"value":"European Journal of Obstetrics & Gynecology and Reproductive Biology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ejogrb.2024.06.030","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2024 Merck Sharp & Dohme LLC, a subsidiary of Merck & Co., Inc., Rahway, NJ, USA. and The Author(s). Published by Elsevier B.V.","name":"copyright","label":"Copyright"}]}}